000			01914nam a2200181 4500
003			OSt
005			20241111170526.0
008			241111b |||||||| |||| 00| 0 eng d
100			_aEric Wei Chiang Chan
245			_aA Case Report of Retracted Publications in Pharmaceutical Science as a Remedy for Research Malpractice
300			_aP355-363
520			_aThe number of retractions of journal articles has sharply increased in recent decades. Objectives: In this case report, excessive retracted publications on the anti-cancer properties of physcion 8-O-β-D-glucopyranoside (PG) in recent years were presented and discussed, in comparison with those of physcion. Materials and Methods: A literature search for technical and review papers on the anti-cancer properties of PG and physcion was conducted via Google Scholar and PubMed. Results: PG and physcion are bioactive anthraquinones. In this study, 13 out of 20 papers (65%) and 3 out of 16 papers (19%) on the anti-cancer properties of PG and physcion were retracted, respectively. The main reason for retraction was the copying of figures from previously published papers. None of the notices of retractions highlighted research malpractice. The word ‘RETRACTION’ printed in red on every page of retracted articles may be a more effective deterrent for authors than retraction notices. Conclusion: This case report exemplifies the retraction of publications on the anti-cancer properties of PG and physcion as a form of remedy for research malpractice, only if the process is properly implemented.
654			_aPhyscion _aPhyscion 8-O-β-D-glucopyranoside _aAnthraquinones _a Retraction _aAnti-cancer properties.
700			_aEric Wei Chiang Chan*
773	0		_0125266 _9109601 _dBanglore Association of Pharmaceutical Tearchers of India _oJP44 _tIndian Journal of Pharmaceutical Education and Research _x0019-5464
942			_cJA
942			_2ddc
999			_c130126 _d130126